低氧对中性粒细胞降解和炎症反应的影响在阿尔法-1抗素缺乏症患者中
María Magallón1,2, Silvia Castillo-Corullón2,3,4, Lucía Bañuls1,2
1Department of Physiology, School of Medicine, University of Valencia, Avda. Blasco Ibáñez, 15, 46010 Valencia, Spain.
Antioxidants (Basel, Switzerland)
|September 28, 2024
概括
缺氧显著增加中性粒细胞脱粒和炎症标记在阿尔法-1抗素缺乏症 (AATD) 患者. 这表明生理氧气水平在AATD病原和炎症中起着关键作用.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 遗传学 遗传学 是一个
背景情况:
- 阿尔法-1抗素缺乏症 (AATD) 是一种炎症状况,其特征是中性粒细胞参与.
- 在AATD中中性粒细胞的激活有助于组织损伤和局部缺氧.
- 以前对中性粒细胞功能的研究往往忽视了生理氧气水平的影响.
研究的目的:
- 为了研究缺氧对中性粒细胞脱粒的作用,在AATD患者.
- 评估缺氧对中性粒细胞在AATD中的细胞因子产生的影响.
主要方法:
- 从54名AATD患者 (MZ,SZ,ZZ基因型) 和7名健康对照 (MM基因型) 中分离了中性粒细胞.
- 细胞被暴露在低氧 (1%O) 中4小时.
- 测量了降粒标记物 (NE,MPO,乳二,MMP-9) 和细胞因子 (IL-8,IL-1β,IL-6,TNF-α,IL-4,IL-10).
主要成果:
- 与对照组相比,低氧显著增加了AATD患者中中性粒细胞弹性酶 (NE),髓氧化酶 (MPO),乳酸铁素和矩阵金属蛋白酶-9 (MMP-9) 的释放.
- 支持炎症的细胞因子IL-8和抗炎症的细胞因子IL-4显示显著增加.
- 瘤亡因子-α (TNF-α) 和IL-10水平在低氧下降.
结论:
- 来自AATD患者的中性粒细胞在生理缺氧下表现出增强的脱粒化.
- 低氧导致AATD中性粒细胞的炎症表型,突显了氧气水平在疾病病理学中的重要性.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
Hypoxia
967
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
967
Acute Respiratory Failure-II
179
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
180
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
180
Inflammation
53.2K
Overview
53.2K


